erythromycin has been researched along with lactoferrin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heimdahl, A; Nord, CE | 1 |
| Gutteberg, TJ; Osbakk, SA; Perstølen, T; Rekdal, O; Svendsen, JS; Ulvatne, H; Vorland, LH | 1 |
| Buurman, WA; Hack, CE; Schultz, MJ; Speelman, P; van Der Poll, T; van Deventer, SJ | 1 |
| Ajello, M; Antonini, G; Giansanti, F; Greco, R; Massucci, MT; Valenti, P | 1 |
| Brouwer, CP; Lupetti, A; Nibbering, PH; Paulusma-Annema, A; Pauwels, EK; Welling, MM | 1 |
| Ida, S; Ishizawa, K; Jia, YX; Kobayashi, S; Kubo, H; Sasaki, H; Sekizawa, K; Suzuki, T; Yamaya, M | 1 |
2 trial(s) available for erythromycin and lactoferrin
| Article | Year |
|---|---|
Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Blood Proteins; Cell Degranulation; Chemokines, CXC; Erythromycin; Humans; In Vitro Techniques; Indicators and Reagents; Infusions, Intravenous; Lactoferrin; Membrane Proteins; Microbial Sensitivity Tests; Neutrophils; Phosphopyruvate Hydratase; Streptococcus pneumoniae | 2000 |
Anti-invasive activity of bovine lactoferrin towards group A streptococci.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cattle; Cell Division; Child; Erythromycin; HeLa Cells; Humans; Lactoferrin; Palatine Tonsil; Pharyngitis; Streptococcus | 2002 |
4 other study(ies) available for erythromycin and lactoferrin
| Article | Year |
|---|---|
Colonization of the oropharynx with pathogenic microorganisms--a potential risk factor for infection in compromised patients.
Topics: Attachment Sites, Microbiological; Bacterial Infections; Clindamycin; Erythromycin; Humans; Immune Tolerance; Lactoferrin; Lactoperoxidase; Lysosomes; Neutropenia; Oropharynx; Pneumonia, Aspiration; Risk | 1985 |
Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cattle; Drug Interactions; Drug Synergism; Erythromycin; Escherichia coli; Gentamicins; Lactoferrin; Microbial Sensitivity Tests; Penicillin G; Staphylococcus aureus; Vancomycin | 1999 |
99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cloxacillin; Erythromycin; Female; Lactoferrin; Male; Mice; Peptide Fragments; Radionuclide Imaging; Rats; Rats, Wistar; Ribosomal Proteins; Staphylococcal Infections; Staphylococcus aureus; Technetium | 2004 |
Erythromycin increases bactericidal activity of surface liquid in human airway epithelial cells.
Topics: Anti-Bacterial Agents; beta-Defensins; Cell Survival; Cells, Cultured; Erythromycin; Gene Expression; Humans; Lactoferrin; Methicillin Resistance; Muramidase; Pseudomonas Infections; Respiratory Mucosa; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Staphylococcal Infections; Trachea | 2005 |